Author

K. M. Kistner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

C. Setz· 1 shared G. Andrieux· 1 shared H. Jumaa· 1 shared H. Zhou· 1 shared J. Jellusova· 1 shared J. Maurer· 1 shared J. Strietz· 1 shared K. Raute· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Setz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Breast cancer stem cell-derived tumors escape from γδ T cell immunosurveillance in vivo by modulating γδ T cell ligands

K. Raute, J. Strietz, G. Andrieux, O. S. Thomas, K. M. Kistner, M. Zintchenko, P. Aichele, H. Zhou, W. Weber, M. Boerries, M. Swamy, J. Maurer, S. Minguet

This study shows that breast cancer stem cells escape γδ T cell immunosurveillance by losing key ligands and antigens, and that this escape can be reversed with Zoledronate or IFN- treatment.

bioRxiv · Apr 4, 2022Immunology

Accumulation of the GSK3 target protein β-catenin is lethal for B cell precursors and malignant B cells

H. Jumaa, K. M. Kistner, C. Setz, M. M. Taketo, H. Jumaa, J. Jellusova

This study shows that β-catenin accumulation caused by GSK3 inhibition leads to reduced survival in B cell precursors and malignant B cells.

bioRxiv · Sep 17, 2021 · PreprintImmunology